160 related articles for article (PubMed ID: 19424698)
1. Post-inflammatory retinal dystrophy in CINCA syndrome.
Rigante D; Stabile A; Minnella A; Avallone L; Ziccardi L; Bersani G; Stifano G; Compagnone A; Falsini B
Rheumatol Int; 2010 Jan; 30(3):389-93. PubMed ID: 19424698
[TBL] [Abstract][Full Text] [Related]
2. Neonatal treatment of CINCA syndrome.
Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
[TBL] [Abstract][Full Text] [Related]
3. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
Goldbach-Mansky R
Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
[TBL] [Abstract][Full Text] [Related]
4. Twenty year follow up of a patient with a new de-novo NLRP3 mutation (S595G) and CINCA syndrome.
Kanariou M; Dracou C; Spanou K; Möller J; Rösen-Wolff A; Schuster V; Roesler J
Klin Padiatr; 2009; 221(6):379-81. PubMed ID: 19890791
[TBL] [Abstract][Full Text] [Related]
5. [Cryopyrin-associated periodic syndromes].
Quartier P; Rodrigues F; Georgin-Lavialle S
Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
[TBL] [Abstract][Full Text] [Related]
6. A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in moyamoya syndrome.
Wohlrab F; Bauknecht C; Meisel C; Dreier JP
Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):e1-3. PubMed ID: 33109682
[No Abstract] [Full Text] [Related]
7. Muckle-Wells treatment with anakinra.
Eungdamrong J; Boyd KP; Meehan SA; Latkowski JA
Dermatol Online J; 2013 Dec; 19(12):20720. PubMed ID: 24365011
[TBL] [Abstract][Full Text] [Related]
8. Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA).
Rigante D; Leone A; Marrocco R; Laino ME; Stabile A
Rheumatol Int; 2011 Dec; 31(12):1661-4. PubMed ID: 21240490
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous neutrophils infiltrates. Case 8. CINCA/NOMID syndrome].
Fraitag S
Ann Pathol; 2011 Jun; 31(3):203-7. PubMed ID: 21737003
[No Abstract] [Full Text] [Related]
10. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
Idorn L; Vissing NH; Jensen L; Herlin T
Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
[TBL] [Abstract][Full Text] [Related]
11. Neonatal urticaria: Could it be CAPS?
Cutts L; Parslew R; Eustace K
Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
[TBL] [Abstract][Full Text] [Related]
12. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
[TBL] [Abstract][Full Text] [Related]
13. Anakinra for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
[TBL] [Abstract][Full Text] [Related]
14. CINCA syndrome in an infant presenting with hydrocephalus.
Turel O; Goknar N; Uzuner S; Kasapcopur O; Cuisset L
Int J Rheum Dis; 2014 Mar; 17(3):346-8. PubMed ID: 24618115
[No Abstract] [Full Text] [Related]
15. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment of CINCA/NOMID Syndrome with Interleukin-1 Blockade.
Macejová Z; Vargová V; Matejka M; Szekanecz Z
Isr Med Assoc J; 2015 Jun; 17(6):389-91. PubMed ID: 26234003
[No Abstract] [Full Text] [Related]
18. [Update in interleukin-1 inhibition].
de Boysson H
Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
[No Abstract] [Full Text] [Related]
19. Urticaria, fever, and hypofibrinogenemia.
Mohr V; Schulz A; Lohse P; Schumann C; Debatin KM; Schuetz C
Arthritis Rheumatol; 2014 May; 66(5):1377. PubMed ID: 24782193
[No Abstract] [Full Text] [Related]
20. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS).
Ramos E; Aróstegui JI; Campuzano S; Rius J; Bousoño C; Yagüe J
Rheumatology (Oxford); 2005 Aug; 44(8):1072-3. PubMed ID: 15840596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
